It is not clear how   Donald J. Trump will approach these issues he has said he favors reducing health care costs, but Republicans, who control Congress, too, have opposed a government role in price setting. One mechanism to control pricing already exists. It is called   rights, and it lets the N. I. H. take back control of a patent on an invention made with federal funding if the drug is not being made available to the public on reasonable terms. The tool has gone unused. 